Application of 3-(1-(S)-(N,N-dimethylamino)ethyl)phenol_Kain Industrial Additive
Background and overview[1][2] Rivastigmine bitartrate (IV) is an anti-Alzheimer’s drug developed by the Swiss Novartis Company, also known as Esnen. It is a carbamate-based reversible cholinesterase inhibitor and belongs to the third generation. A drug that improves the function of the choline system. In addition to inhibiting acetylcholinesterase, it can also inhibit butyrylcholinesterase, exerting a…
